Invention Application
- Patent Title: TETRACYCLINE COMPOUNDS
-
Application No.: US15446831Application Date: 2017-03-01
-
Publication No.: US20170334841A1Publication Date: 2017-11-23
- Inventor: Yonghong Deng , Louis Plamondon , Cuixiang Sun , Xiao-Yi Xiao , Jingye Zhou , Joyce A. Sutcliffe , Magnus P. Ronn
- Applicant: Tetraphase Pharmaceuticals,Inc.
- Main IPC: C07C311/08
- IPC: C07C311/08 ; C07D295/15 ; C07C237/26 ; C07C307/10 ; C07C311/09 ; C07C311/13 ; C07C311/21 ; C07C311/29 ; C07C311/44 ; C07D233/84 ; C07D233/60 ; C07D231/18 ; C07D223/06 ; C07D213/82 ; C07D213/74 ; C07D213/70 ; C07D211/60 ; C07D211/54 ; C07D209/52 ; C07D209/44 ; C07D207/16 ; C07D207/12 ; C07D205/04 ; C07D307/64 ; C07C2603/46 ; C07C2601/02 ; C07C2603/40 ; C07C2603/44 ; C07C2601/16 ; C07C2601/04 ; C07C2601/14 ; C07C2601/08
Abstract:
The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.
Information query
